Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Tunis Med ; 102(4): 235-240, 2024 Apr 05.
Article in French | MEDLINE | ID: mdl-38746964

ABSTRACT

INTRODUCTION-AIM: Flexible insulin therapy is currently considered the gold standard therapy of type 1 diabetes. We aimed to study the evolution of glycemic control, weight and nutritional intake of a group of patients with type 1 diabetes, three months after the initiation of functional insulin therapy (FIT). METHODS: This was a prospective longitudinal study having included 30 type 1 diabetic patients hospitalized for education to FIT. Each patient underwent an assessment of glycemic control (glycated hemoglobin (A1C) and number of hypoglycemia), weight and nutritional intake before FIT and 3 months after the initiation of this educative approach. RESULTS: The mean age of patients was 21,8 ± 7,9 years and the sex ratio was 0,5. The mean duration of diabetes was 7,2 ± 6 years. Three months after initiation of FIT, we observed a significant lowering of A1C, which went from 9,2 ± 1,6% to 8,3 ± 1,4% (p<0,001) of the number of minor hypoglycemia (p=0,001) and that of severe hypoglycemia (p= 0,021). the average weight went from 64,6 ± 13,1 kg to 65,5 ± 13,5 kg (p = 0,040) with a significant increase in BMI (p = 0,041). Weight gain was observed in 67% of patients. This weight gain contrasted with a significant decrease in caloric (p = 0,040) and in carbohydrates intakes (p = 0,027). CONCLUSION: Weight gain, associated with better glycemic control, should encourage the healthcare team to strengthen therapeutic education of patients undergoing FIT in order to limit weight gain.


Subject(s)
Body Weight , Diabetes Mellitus, Type 1 , Hypoglycemic Agents , Insulin , Humans , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/blood , Female , Male , Insulin/administration & dosage , Insulin/therapeutic use , Adult , Young Adult , Prospective Studies , Longitudinal Studies , Adolescent , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Body Weight/physiology , Glycated Hemoglobin/analysis , Glycated Hemoglobin/metabolism , Hypoglycemia/prevention & control , Hypoglycemia/chemically induced , Hypoglycemia/epidemiology , Glycemic Control/methods , Energy Intake , Weight Gain/physiology , Weight Gain/drug effects , Time Factors , Blood Glucose/analysis , Blood Glucose/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...